Cargando…
The effect of pretreatment BMI on the prognosis and serum immune cells in advanced LSCC patients who received ICI therapy
This study aims to evaluate the prognosis and serum immune cells of patients with different pretreatment body mass index (BMI) values. The data of 61 newly diagnosed patients with advanced lung squamous cell carcinoma (LSCC) who received immune checkpoint inhibitors (ICIs) combined with chemotherapy...
Autores principales: | Wang, Fei, Zhou, Lei, Chen, Na, Li, Xiaoming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7909129/ https://www.ncbi.nlm.nih.gov/pubmed/33663076 http://dx.doi.org/10.1097/MD.0000000000024664 |
Ejemplares similares
-
Pretreatment “prognostic nutritional index” as an indicator of outcome in lung cancer patients receiving ICI-based treatment: Systematic review and meta-analysis
por: Shao, Yifeng, et al.
Publicado: (2022) -
Therapeutic effectiveness and safety of sequential ICIs with radiotherapy for symptomatic brain and bone metastases in NSCLC patients
por: Tang, Cuiping, et al.
Publicado: (2022) -
Pretreatment Serum Lactate Dehydrogenase and N Classification Predict Long-Term Survival and Distant Metastasis in Patients With Nasopharyngeal Carcinoma Who Have A Positive Family History of Cancer
por: Zhang, Wenna, et al.
Publicado: (2015) -
Serum SALL4 as a predictive biomarker for the prognosis of patients with hepatocellular carcinoma who underwent nonsurgical treatment
por: Chen, Zhixian, et al.
Publicado: (2022) -
Correlation Between the NLRP3 Inflammasome and the Prognosis of Patients With LSCC
por: Xue, Yi, et al.
Publicado: (2019)